Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.
Entrada Therapeutics Inc. a biopharmaceutical company aiming to transform the lives of patients through its new class of medicines, has announced recipients of its inaugural Entrada DREAMS Grant Program.
